0001562762-24-000015.txt : 20240201 0001562762-24-000015.hdr.sgml : 20240201 20240201100055 ACCESSION NUMBER: 0001562762-24-000015 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240201 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240201 DATE AS OF CHANGE: 20240201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHEMED CORP CENTRAL INDEX KEY: 0000019584 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 310791746 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08351 FILM NUMBER: 24585311 BUSINESS ADDRESS: STREET 1: SUITE 2600 STREET 2: 255 E FIFTH ST CITY: CINCINNATI STATE: OH ZIP: 45202 BUSINESS PHONE: (513)762-6690 MAIL ADDRESS: STREET 1: SUITE 2600 STREET 2: 255 E FIFTH STREET CITY: CINCINNATI STATE: OH ZIP: 45202-4726 FORMER COMPANY: FORMER CONFORMED NAME: ROTO-ROOTER INC DATE OF NAME CHANGE: 20030613 FORMER COMPANY: FORMER CONFORMED NAME: CHEMED CORP DATE OF NAME CHANGE: 19920703 8-K 1 che-20240201x8k.htm 8-K che-20240201x8k
false000001958400000195842024-02-012024-02-01

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported):

February 1, 2024

CHEMED CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

     1-8351

  31-0791746

(State or other
‎jurisdiction of
‎incorporation)

(Commission File Number)

(I.R.S. Employer
‎Identification
‎Number)

2600 First Financial Center, 255 East 5th Street, Cincinnati, OH 45202

(Address of principal executive offices)             (Zip Code)

Registrant's telephone number, including area code:

(513) 762-6690

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

[_]      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[_]      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)

[_]      Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240-14d-2(b))

[_]      Pre-commencement communications pursuant to Rule 13e-4 (c) under Exchange Act (17 CFR 240-13e-4(c))

Securities registered pursuant to 12(b) of the Act:

 

Title of each class

 

Trading symbol

Name of each exchange on which

registered

Capital stock $1 par value

CHE

NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.  [_]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [_]

Page 1 of 3

Item 5.02 (e) Departure of Directors or Certain Officers; Election of Directors: Appointment of Certain Officers, Compensatory Arrangements of Certain Officers.

To reflect his new role within the organization as an advisor to Chemed Corporation’s (the “Company’s”) Chief Executive Officer, the Compensation Committee granted David P. Williams 6,424 Performance Share Units and agreed to pay him a monthly salary of $38,750. Under the terms of the grant, the Performance Share Units will vest into Company shares depending on the Company’s total shareholder return over the next three calendar years. Mr. Williams may continue to participate in benefits made generally available to employees and the Company may terminate Mr. Williams’ employment on twelve months’ written notice.

The above description is qualified in its entirety by the complete text of the grant letter, attached hereto as Exhibit 10.1.

Item 9.01 Financial Statements and Exhibits

d)   Exhibit

 10.1 David P. Williams Performance Share Units Grant Letter dated January 29, 2024

  104 The cover page from this Current Report on Form 8-K formatted in Incline XBRL

Page 2 of 3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CHEMED CORPORATION

Dated:   February 1, 2024

By:

/s/ Brian C. Judkins

Brian C. Judkins

Chief Legal Officer

Page 3 of 3

 EX-10.1 2 che-20240201xex10_1.htm EX-10.1 Exhibit 101 DPW AGREEMENT

 

 





















January 29, 2024





Dear Mr. Williams:



In connection with your transition from Chief Financial Officer and Executive Vice President of Chemed Corporation (the “Company”) to an employee in an advisory role to the Chief Executive Officer, I am please to inform you that you have been granted a target number of  6,424 share units, which are the equivalent of one share of the Company’s Capital Stock (“Capital Stock”), par value $1.00 per share (“Performance Share Units”), under the 2022 Stock Incentive Plan (the “Plan”).  Subject to the terms and conditions of this Agreement and the Plan and depending on the Company’s performance, as set forth below, you may earn between one hundred percent (100%) to two hundred percent (200%) of the target number of Performance Share Units.  Capitalized terms used in this Agreement without definition shall have the meanings set forth in the Plan, unless otherwise stated herein.



1.  The Performance Share Units (and any additional Dividend Share Units with respect to such Performance Share Units, as set forth in Section 3) shall vest and be earned based on the Company’s three-year total shareholder return percentile ranking as compared to the Peer Companies, as defined below (“3-Year TSR Percentile”) for the performance period beginning January 1, 2024 and ending December 31, 2026 (the “Performance Period”) as set forth below (the “Performance Goal”).



2.  No later than March 15, 2027, the Company’s Compensation/Incentive Committee (the “Committee”) shall determine the extent to which each Performance Goal has been achieved and shall determine the number of Performance Share Units that has been earned by you. The number of Performance Share Units to be vested and earned shall be based on the degree of achievement of the Performance Goal, in accordance with the following tables.





 

 

 



 

3-Year TSR Percentile

Percentage of Target Shares

 

Maximum

 

Greater than 90th

200.0%

 



 

75th

150.0%

 



 

60th

125.0%

 

Target

 

Less than 50th

100.0%

 

   





 

For performance levels between those appearing in the above table, the number of Performance Share Units to be vested and earned shall be interpolated between the next closest performance levels appearing in the tables.  The Committee has no discretion to increase some or all of the number of shares of Capital Stock that would otherwise be earned as a result of the satisfaction of the Performance Goal.

3-Year TSR Percentile means the percentile ranking of the Company’s 3-Year TSR as compared to the 3-Year TSR of each of the Peer Companies, where 3-Year TSR means, for the Company and each of the Peer Companies, a company’s total shareholder return, which is equal to Closing Average Stock Price divided by the Opening Average Stock Price raised to the 1/3 power, minus one (1).

Closing Average Stock Price means the average of a company’s closing stock price over the thirty (30) trading days ending on the last day of the Performance Period, or in the case of a Change in Control (as defined in the Chemed Corporation Change in Control Severance Plan, the “CIC Severance Plan”), ending on the date of the Change in Control or some earlier date, as determined by the Committee, where such price takes into account dividends paid on a company’s stock during the Performance Period, assuming same day reinvestment of the dividends into shares of the company’s stock at the closing stock price on the ex-dividend date. 

Opening Average Stock Price means the average of a company’s closing stock price over the thirty (30) trading days ending on the first day of the Performance Period.  

Peer Companies means the list of companies appearing in Exhibit A of this Agreement.  In the event of a merger, acquisition, or other similar business combination of a Peer Company during the Performance Period where the Peer Company is not the surviving entity or a Peer Company is taken private or is no longer publicly traded in the United States during the Performance Period, the company shall no longer be a Peer Company.  In the event of a bankruptcy, liquidation, or dissolution of a Peer Company or a Peer Company otherwise ceases to conduct operations during the Performance Period, its 3-Year TSR shall be deemed to be -100%.   

Any fractional shares resulting from the determination of the number of Performance Share Units to be earned and vested shall be rounded to the nearest whole number of shares of Capital Stock.

3.  If the Company pays a cash dividend during the Performance Period, your number of target Performance Share Units, including any such previous Dividend Share Units (as defined below), will increase on the dividend payment date by a number of units equal to the per share cash dividend amount multiplied by such number of target Performance Share Units divided by the Company’s closing stock price on the dividend payment date (“Dividend Share Units”).    

4.  You will not, except as otherwise specifically required or permitted by this Agreement, sell, exchange, transfer, pledge, hypothecate or otherwise dispose of any of the Performance Share Units or any interest therein.

5.  Any provision of this Agreement to the contrary, the Company may take such steps as it believes necessary or desirable to obtain sufficient funds from you to pay all taxes, if any, required by law to be withheld in respect of the Performance Share Units including, but not limited to, requiring payments to the Company by you or on your behalf and/or taking deductions from amounts payable by the Company to you or on your behalf. 



6.  Each of the parties hereto agrees to execute and deliver all consents and other instruments and to take all other action deemed necessary or desirable by counsel for the Company to carry out each term of this Agreement.  Each party recognizes that the other party has no adequate remedy at law for breach of this Agreement and recognizes, consents, and agrees that the other party shall be entitled to an injunction or decree of specific performance directed to the other party that the provisions of this Agreement be carried out.



 

 

 

7.  (a)  Any notice to the Company under or pursuant to this Agreement shall be deemed to have been given if and when delivered in person to the Secretary of the Compensation/Incentive Committee or if and when mailed by certified or registered mail to the Secretary of the Compensation/Incentive Committee at Suite 2600, 255 East Fifth Street, Cincinnati, Ohio 45202, or such other address as the Company may from time to time designate in writing by notice to you given pursuant to paragraph 9(b) hereof.



(b)  Any notice to you under or pursuant to this Agreement shall be deemed to have been given if and when delivered to you in person or if and when mailed by certified or registered mail to you at your address hereinabove given or such other address as you may from time to time designate in writing by notice to the Company given pursuant to paragraph 9(a) above.



8. Notwithstanding any remedy provided for in this Agreement, nothing in this Agreement shall preclude the Company from taking any other action or enforcing any other remedy available to the Company.



9.  In consideration for the grant of Performance Share Units set forth above, you agree as follows:

(a) You have been and shall be provided during your employment with the Company, and shall not disclose to anyone or make use of any, trade secrets and proprietary or confidential information of the Company or an affiliate, including such trade secrets and proprietary or confidential information of any customer or other entity to which the Company owes an obligation not to disclose such information, which you acquired or acquire during the period of your employment, including, without limitation, records kept in the ordinary course of business, except (i) as such disclosure or use may be required or appropriate in connection and in furtherance of your work as an employee of the Company or an affiliate, (ii) when required to do so by a court of law, governmental agency or administrative or legislative body (including a committee thereof) with apparent jurisdiction to order you to divulge, disclose or make accessible such information or (iii) as to such confidential information that becomes generally known to the public or trade without your violation of this Paragraph 9(a). You hereby agree that prior to or immediately following your termination of employment with the Company, unless otherwise agreed, you shall return all Company property in your possession (and sign a written acknowledgement to this effect), including but not limited to all computer software, computer access codes, laptops, cell phones, personal handheld devices, keys and access cards, credit cards, vehicles, telephones, office equipment and all copies (including drafts) of any documentation or information (however and wherever stored) relating to the business of the Company or an affiliate. For the avoidance of doubt, nothing in this Agreement prohibits you from (i) filing and, as provided for under Section 21F of the Securities Exchange Act of 1934 (“Section 21F”), maintaining the confidentiality of a claim with the Securities and Exchange Commission (the “SEC”); (ii) providing confidential information to the SEC, or providing the SEC with information that would otherwise violate this Section 9(a), to the extent permitted by Section 21F; (iii) cooperating, participating or assisting in an SEC investigation or proceeding without notifying the Company; or (iv) receiving a monetary award as set forth in Section 21F.



(b) For and in consideration of the grant of Performance Share Units pursuant to the terms hereof, and in recognition of the fact that you will be provided confidential information, customer goodwill, and other valuable rights of the Company or an affiliate which must be protected, and ancillary to those agreements between the parties, you covenant and agree that you will not, at any time during the longer of (i) the duration of the Performance Period, or (ii) the duration of your employment with the Company or any affiliate, and in either case, for a

 

 

 

period of twelve (12) months thereafter (such longer period, the “Covenant Period”), directly or indirectly, solicit or induce any customer of the Company or an affiliate in an attempt to divert, transfer, or otherwise take away business from the Company or an affiliate. You further agree that during the Covenant Period you shall not, directly or indirectly, induce, attempt to induce, or aid others in inducing, an exempt employee of the Company or any affiliate to accept employment or affiliation with another firm or corporation engaging in such business or activity of which you are an employee, director, owner, partner or consultant. 



(c) In consideration of the grant of Performance Share Units pursuant to the terms hereof, and in recognition of the fact that you will be provided confidential information, customer goodwill, and other valuable rights of the Company or an affiliate which must be protected, and ancillary to those agreements between the parties, you covenant and agree that you will not, at any time during the Covenant Period directly or indirectly, engage in any business or in any activity related to the  businesses operated by the Company or its Subsidiaries during which time you were employed by the Company. Notwithstanding the foregoing, nothing contained in this Agreement shall prevent you from being an investor in securities of a competitor listed on a national securities exchange or actively traded over-the-counter so long as such investments are in amounts not significant as compared to your total investments or to the aggregate of the outstanding securities of the issuer of the same class or issue of the specific securities involved.



(d) You agree that the obligations set forth in this Paragraph 9 are in addition to and not in limitation of any obligations that would otherwise exist as a matter of law.



(e) You agree that the time and geographic restrictions set forth in this Paragraph 9 are reasonable and that, given your role with the Company, the geographic scope of the covenants set forth in this Paragraph is global.  In the event that any court of competent jurisdiction determines that the duration or the geographic scope, or both, are unreasonable and that such provision is to that extent unenforceable, you and the Company agree that the provision shall remain in full force and effect for the greatest time period and in the greatest area that would not render it unenforceable. 



(f) In the event that you violate any provision of this Paragraph 9, the Company shall be entitled to cancel and you shall forfeit any and all Performance Share Units granted hereunder.



10.   By execution of this Agreement, you confirm and acknowledge that as of the date hereof, (i) you have resigned your roles as Executive Vice President and Chief Financial Officer of the Company, (ii) your Employment Agreement, dated as of December 1, 2006 (as subsequently amended) has been terminated and is no longer in force or effect, and (iii) you are no longer entitled to any benefits under the Company’s Change in Control Severance Plan.  You will remain a full-time employee of the Company, serve in a role as an advisor to the Chief Executive Officer, and may be invited, from time to time, to attend board meetings and provide advice to the Board of Directors. Your employment may be terminated by the Company for any reason or no reason upon written notice of no less than twelve (12) months.  You will be entitled to participate in those benefits made available to other employees generally, and your salary will be $38,750 per month during your continued employment, payable in accordance with the Company’s standard payroll practices.  Any annual incentive payments or equity grants will be at the complete discretion of the Board of Directors or the Committee, as applicable.



11.  The Company will not disparage, impugn, or otherwise take any action which could reasonably be expected to affect your personal or professional reputation.  You will not disparage, impugn, or otherwise

 

 

 

take any action which could reasonably damage the reputation of the Company, any of its affiliates or their employees, directors, officers, employees, or business practices. 



12.This Agreement has been executed pursuant to the Plan of the Company, and the Plan is incorporated herein by reference.



13.  The Company may cancel, forfeit or recoup any rights or benefits of, or payments to, you hereunder, including but not limited to any Capital Stock issued by the Company or the proceeds from the sale of any such Capital Stock, under any current or future compensation recovery policy that it may establish and maintain from time to time to meet listing requirements that may be imposed in connection with the Dodd-Frank Wall Street Reform and Consumer Protection Act or otherwise.



14.  This Agreement shall be binding upon and inure to the benefit of (a) the Company, its successors and assigns, and (b) you, and to the extent applicable, any beneficiary in the event of your death.



15.  This Agreement has been executed, and it and any shares of Capital Stock that are to be delivered, in accordance with the laws of the State of Ohio, the state in which the Company maintains its principal executive offices, and the validity, interpretation, performance and enforcement of this Agreement shall be governed by the laws of the State of Ohio.

16.  Upon the occurrence of a Change in Control (as defined in the CIC Severance Plan) during the Performance Period, the number of Performance Share Units to be vested and earned shall be based on the greater of (i) the degree of achievement of the Performance Goal as of the date of the Change in Control or some earlier date, as determined by the Committee, in accordance with the tables set forth in Section 2 of this Agreement; or (ii) the target number of Performance Share Units; provided, however, that the date on which these Performance Share Units shall become vested and earned will be January 1, 2027, subject to the terms of Section 5 of this Agreement where such date is to be considered the date on which the Committee determines the actual number of shares of Capital Stock to be delivered to you and your employment is with the surviving or successor entity; provided, however, that upon a termination of your employment (i) for reasons other than Cause; or (ii) for Good Reason (as defined in the CIC Severance Plan), the Performance Share Units shall become immediately vested and earned.  Upon the Change in Control, the Company shall cause the surviving entity to issue replacement Performance Share Units (“Replacement Award”), which units shall be the equivalent of one share of common stock of the surviving entity.  The number of Performance Share Units subject to such Replacement Award shall be determined based on the Company’s stock price immediately before the Change in Control and the stock price of the surviving entity immediately after the Change in Control, such that the total value of the Performance Share Units immediately prior to the Change in Control is equal to the value of the Replacement Award immediately after the Change in Control.  Such Replacement Award shall vest immediately prior to any subsequent transaction with respect to the surviving entity (or parent or subsidiary company thereof) of substantially similar character to a Change in Control.  Notwithstanding anything to the contrary contained herein, if the surviving entity is no longer publicly traded on a United States exchange at the date of the Change in Control or the conversion into a Replacement Award is not properly executed, then such Performance Share Units shall become vested and earned immediately following the Change in Control.  By accepting this grant and Agreement, you explicitly agree that, to the extent there is a conflict between the terms of this Section 16 and the CIC Severance Plan, the terms of this Section 16 shall control.



Very truly yours,



CHEMED CORPORATION

 

 

 







Executed and agreed toBy: /s/ Brian C. Judkins

as of:     Brian C. Judkins

    Vice President, Secretary

    and Chief Legal Officer

____________________________



Date: January 29, 2024

 

 

 







EXHIBIT A:  Peer Companies List





ABM Industries, Inc.

Acadia Healthcare Co., Inc.

Amedisys, Inc.

Brookdale Senior Living, Inc.

Clean Harbors, Inc.

Comfort Systems USA, Inc.

Encompass Health Corp.

Healthcare Services Group, Inc.

LHC Group, Inc.

National Healthcare Corp.

Pediatrix Medical Group

   (formerly MEDNAX,INC.)

RadNet, Inc.

Rollins, Inc.

Select Medical Holdings Corp.

Stericycle, Inc.

Team, Inc.

Tetra Tech, Inc.

The Ensign Group, Inc.



 

 

EX-101.SCH 3 che-20240201.xsd EX-101.SCH 00090 - Document - Document And Entity Informationlink:presentationLinklink:calculationLinklink:definitionLink EX-101.LAB 4 che-20240201_lab.xml EX-101.LAB Document And Entity Information [Abstract] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Class of Stock [Line Items] Class of Stock [Line Items] Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity File Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Entity Emerging Growth Company Entity Central Index Key Entity Central Index Key Amendment Flag EX-101.PRE 5 che-20240201_pre.xml EX-101.PRE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document And Entity Information
Feb. 01, 2024
Document And Entity Information [Abstract]  
Document Type 8-K
Document Period End Date Feb. 01, 2024
Entity Registrant Name CHEMED CORPORATION
Entity Incorporation, State or Country Code DE
Entity File Number 1-8351
Entity Tax Identification Number 31-0791746
Entity Address, Address Line One 2600 First Financial Center
Entity Address, Address Line Two 255 East 5th Street
Entity Address, City or Town Cincinnati
Entity Address, State or Province OH
Entity Address, Postal Zip Code 45202
City Area Code 513
Local Phone Number 762-6690
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Title of 12(b) Security Capital stock $1 par value
Trading Symbol CHE
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0000019584
Amendment Flag false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 23 1 false 0 0 false 0 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://www.sec.gov/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports che-20240201.xsd che-20240201_lab.xml che-20240201_pre.xml che-20240201x8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "che-20240201x8k.htm": { "dts": { "schema": { "local": [ "che-20240201.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "che-20240201_lab.xml" ] }, "presentationLink": { "local": [ "che-20240201_pre.xml" ] }, "inline": { "local": [ "che-20240201x8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://www.sec.gov/role/DocumentDocumentAndEntityInformation", "longName": "00090 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_2_1_2024_To_2_1_2024", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "che-20240201x8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_1_2024_To_2_1_2024", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "che-20240201x8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Document And Entity Information [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001562762-24-000015-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001562762-24-000015-xbrl.zip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end XML 16 che-20240201x8k_htm.xml IDEA: XBRL DOCUMENT 0000019584 2024-02-01 2024-02-01 false 0000019584 8-K 2024-02-01 CHEMED CORPORATION DE 1-8351 31-0791746 2600 First Financial Center 255 East 5th Street Cincinnati OH 45202 513 762-6690 false false false false Capital stock $1 par value CHE NYSE false